Gaurav Shah, CEO at ROCKET PHARMACEUTICALS, INC. (RCKT), sold 55,684 shares at $3.09 ($172K) on 2026-05-21, disclosed to the SEC on 2026-05-26.
Seasonal sale ($172k) by CEO — this insider has traded RCKT in May in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| Filing → |
| RCKT | SELL | 2026-05-21 | $7K | — | Filing → |
| RCKT | SELL | 2026-05-14 | $10K | — | Filing → |
| RCKT | SELL | 2026-02-20 | $20K | — | Filing → |